Fig. 5From: Targeted delivery of immuno-RNase may improve cancer therapyCytotoxicity to HO-8910PM cells by gel electrophoresis fluorescence of DNA after 48 h. Lane 1: Marker; Lane 2: HO-8910PM cells with 0.4 μmol/L ONC-V3. The cells treated with high doses of the ONC-V3 and Melittin appear in a ladder patternBack to article page